Advertisement
EpiPen price backlash comes as consumers pay greater share

EpiPen price backlash comes as consumers pay greater share

By Adam Rubenfire  |  August 25, 2016

The controversy surrounding Mylan's EpiPen pricing suggests drugmakers have been slow to adapt to an environment in which millions of Americans must pay thousands of dollars out of pocket before their coverage kicks in.

Premier Q4 profits decline amid workforce shake-up

By Adam Rubenfire  |  August 24, 2016

Healthcare group purchasing and services company Premier reported a slight decrease in fourth-quarter profit due to severance-related costs in its data software and consulting division.

Are physicians too close with devicemaker sales reps?

Are physicians too close with devicemaker sales reps?

By Adam Rubenfire  |  August 12, 2016

A new study warns that American operating rooms may be relying too much on medical-device salespeople for technical assistance and that loyalty between surgeons and representatives may contribute to rising hospital costs.

Price of drug that reverses opioid overdose on the rise

By Maria Castellucci  |  August 02, 2016

The price of naloxone, a drug used to reverse the effects of an opioid overdose, has skyrocketed in the past few years, according to an analysis by Truven Health Analytics, a research and data firm owned by IBM Corp.

Regional and niche GPOs gain popularity

By Adam Rubenfire  |  July 29, 2016

The expansion of a group purchasing organization serving the public health sector and the recent launch of similar organizations reflect new demands from providers who are faced with an increasingly consolidated GPO market, experts say.

Helium hunters strike the mother lode

Helium hunters strike the mother lode

By Modern Healthcare  |  July 16, 2016

The helium shortage is no more—thanks to a device using some duct tape, plastic piping, a folding table and some other decidedly low-tech components.

CMS and FDA advocate for device identifiers on claims forms

CMS and FDA advocate for device identifiers on claims forms

By Adam Rubenfire  |  July 14, 2016

The heads of the CMS and the Food and Drug Administration want universal health insurance claims forms to include unique device identifiers. The UDI would improve post-market surveillance and provide for better value-based reimbursement based on device performance, they say.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.